Tempus is a medical startup founded in 2015 by Eric Lefkofsky as its Chief Executive Officer. This medical startup is based in Chicago and was made to help find a solution to cancer-related cases by bringing the power of artificial intelligence to healthcare. It uses modern technology like machine learning and genomic sequence when examining the patient’s tumor to come with an accurate diagnosis to help combat the problem. Eric Lefkofsy is also targeting through his startup to expand its genomic sequencing technology to assist in combating illnesses like diabetes and depression.
Tempus is among the top-notch innovators in the precision medicine movement. With advanced technology, it can consolidate its research on molecular and clinical data to come up with more advanced ways of combating this tumor disease and other illnesses. The company is looking forward to coming up with an A.I. compatible system to promote an outstanding and accurate diagnosis for high efficacy.
Eric Lefkofsky, through his company, has come up with various approaches that will offer customized treatments for anyone who has cancer. The strategy entails three significant stages. The first stage is the generation of genomic results, followed by the transformation of unstructured results, and lastly, delivery of insights that are actionable through the Tempus’ data research platform.
The Tempus’ data research platform plays a significant role in fighting cancer. First, it applies the use of advanced analytics and technology to come up with the correct diagnosis for treatment. Secondly, it helps in analyzing information of patients with the same molecular and clinical character to come up with the right therapeutical intervention.
Indeed, Eric Lefkofsky has played a significant role in the fight against cancer. Besides being the C.E.O. of Tempus, he is the founding partner of Lightbank and a higher role to play in Uptake Technologies, Mediaocean, InnerWorkings, and Echo Global Logistics, to name a few.